NCT00309192View on ClinicalTrials.gov

Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Diabetes MellitusMacular Edema
Interventions
DRUG

Triamcinolone Acetonide

Intravitreal Injection 4mg single dose

PROCEDURE

Grid laser

Grid laser as specified in ETDRS

PROCEDURE

Sham Injection

Simulation procedure for triamcinolone injection

Trial Locations (7)

47011

IOBA - Instituto Universitario de Oftalmobiología Aplicada, Valladolid

Unknown

INGO - Instituto Galego de Oftalmoloxia, Santiago de Compostela

Clínica Universitaria de Navarra, Pamplona

Instituto Oftalmológico de Alicante, Alicante

Hospital de la Vall D´Hebrón, Barcelona

Hospital Clínico Universitario San Carlos, Madrid

Hospital General Universitario Reina Sofía, Murcia

All Listed Sponsors
collaborator

Fondo de Investigacion Sanitaria

OTHER

lead

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

OTHER

NCT00309192 - Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema | Biotech Hunter | Biotech Hunter